Lilyan C. Charca

Santa Coloma De Gramenet, CT 33011, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multisite Atherosclerosis and SCORE2-Based Risk Stratification in Psoriatic Arthritis: A Phenotype-Dependent Role of Vascular Territories.

Multisite Atherosclerosis and SCORE2-Based Risk Stratification in Psoriatic Arthritis: A Phenotype-Dependent Role of Vascular Territories.

Journal: Biomedicines

Published: May 09, 2026

Serum Urate as a Cardiometabolic Risk Enhancer Beyond SCORE2 in Psoriatic Arthritis.

Serum Urate as a Cardiometabolic Risk Enhancer Beyond SCORE2 in Psoriatic Arthritis.

Journal: Journal of clinical medicine

Published: April 03, 2026

Cost-efficiency of imaging strategies for detecting subclinical atherosclerosis in psoriatic arthritis.

Cost-efficiency of imaging strategies for detecting subclinical atherosclerosis in psoriatic arthritis.

Journal: Clinical rheumatology

Published: August 22, 2025

Incremental value of carotid intima-media thickness beyond SCORE2 in identifying subclinical atherosclerosis in PsA.

Incremental value of carotid intima-media thickness beyond SCORE2 in identifying subclinical atherosclerosis in PsA.

Journal: Rheumatology (Oxford, England)

Published: August 21, 2025

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study.

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study.

Journal: Frontiers in medicine

Published: March 10, 2021

Structural damage is not a major driver of disease impact in patients with long-standing psoriatic arthritis undergoing systemic therapy.

Structural damage is not a major driver of disease impact in patients with long-standing psoriatic arthritis undergoing systemic therapy.

Journal: Joint bone spine

Published: September 16, 2020

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis.

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis.

Journal: Archives of medical science : AMS

Published: July 31, 2020

Performance of the ASAS Health Index for the Evaluation of Spondyloarthritis in Daily Practice.

Performance of the ASAS Health Index for the Evaluation of Spondyloarthritis in Daily Practice.

Journal: The Journal of rheumatology

Published: April 13, 2020

Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis.

Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis.

Journal: Clinical rheumatology

Published: February 20, 2020

Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study.

Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study.

Journal: Drugs & aging

Published: November 21, 2019

Distribution of the components of the MDA response among patients with psoriatic arthritis with and without an acceptable symptomatic state.

Distribution of the components of the MDA response among patients with psoriatic arthritis with and without an acceptable symptomatic state.

Journal: Clinical and experimental rheumatology

Published: October 28, 2019

Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical setting.

Disease Activity in Psoriatic Arthritis Index and Psoriatic Arthritis Impact of Disease Questionnaire: correlation and sensitivity to change in a real clinical setting.

Journal: Clinical and experimental rheumatology

Published: September 03, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026